Results
|
|
10321.
|
Rituximab, bendamustine and cytarabine (R-BAC) in patients with relapsed-refractory aggressive B-cell lymphoma. [electronic resource] by
- Tisi, Maria Chiara
- Paolini, Rossella
- Piazza, Francesco
- Ravelli, Erika
- Tecchio, Cristina
- Sartori, Roberto
- Famengo, Barbara
- D'Amore, Emanuele Stefano Giovanni
- Carli, Giuseppe
- Perbellini, Omar
- Di Bona, Eros
- Ruggeri, Marco
- Visco, Carlo
Producer: 20190819
In:
American journal of hematology vol. 93
Availability: No items available.
|
|
|
10322.
|
Rituximab primarily targets an intra-clonal BCR signaling proficient CLL subpopulation characterized by high CD20 levels. [electronic resource] by
- Pavlasova, Gabriela
- Borsky, Marek
- Svobodova, Veronika
- Oppelt, Jan
- Cerna, Katerina
- Novotna, Jitka
- Seda, Vaclav
- Fojtova, Miloslava
- Fajkus, Jiri
- Brychtova, Yvona
- Doubek, Michael
- Pospisilova, Sarka
- Mayer, Jiri
- Mraz, Marek
Producer: 20190513
In:
Leukemia vol. 32
Availability: No items available.
|
|
|
10323.
|
Rituximab, plasma exchange and immunoglobulins: an ineffective treatment for chronic active antibody-mediated rejection. [electronic resource] by
- Piñeiro, Gastón J
- De Sousa-Amorim, Erika
- Solé, Manel
- Ríos, José
- Lozano, Miguel
- Cofán, Frederic
- Ventura-Aguiar, Pedro
- Cucchiari, David
- Revuelta, Ignacio
- Cid, Joan
- Palou, Eduard
- Campistol, Josep M
- Oppenheimer, Federico
- Rovira, Jordi
- Diekmann, Fritz
Producer: 20190910
In:
BMC nephrology vol. 19
Availability: No items available.
|
|
|
10324.
|
|
|
|
10325.
|
|
|
|
10326.
|
|
|
|
10327.
|
|
|
|
10328.
|
Clinical and therapeutic predictors of disease outcomes in AQP4-IgG+ neuromyelitis optica spectrum disorder. [electronic resource] by
- Kunchok, Amy
- Malpas, Charles
- Nytrova, Petra
- Havrdova, Eva Kubala
- Alroughani, Raed
- Terzi, Murat
- Yamout, Bassem
- Hor, Jyh Yung
- Karabudak, Rana
- Boz, Cavit
- Ozakbas, Serkan
- Olascoaga, Javier
- Simo, Magdolna
- Granella, Franco
- Patti, Francesco
- McCombe, Pamela
- Csepany, Tunde
- Singhal, Bhim
- Bergamaschi, Roberto
- Fragoso, Yara
- Al-Harbi, Talal
- Turkoglu, Recai
- Lechner-Scott, Jeannette
- Laureys, Guy
- Oreja-Guevara, Celia
- Pucci, Eugenio
- Sola, Patrizia
- Ferraro, Diana
- Altintas, Ayse
- Soysal, Aysun
- Vucic, Steve
- Grand'Maison, Francois
- Izquierdo, Guillermo
- Eichau, Sara
- Lugaresi, Alessandra
- Onofrj, Marco
- Trojano, Maria
- Marriott, Mark
- Butzkueven, Helmut
- Kister, Ilya
- Kalincik, Tomas
Producer: 20210119
In:
Multiple sclerosis and related disorders vol. 38
Availability: No items available.
|
|
|
10329.
|
|
|
|
10330.
|
Bayesian Population Model of the Pharmacokinetics of Venetoclax in Combination with Rituximab in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia: Results from the Phase III MURANO Study. [electronic resource] by
- Deng, Rong
- Gibiansky, Leonid
- Lu, Tong
- Agarwal, Priya
- Ding, Hao
- Li, Xiaobin
- Kshirsagar, Smita
- Lu, Dan
- Li, Chunze
- Girish, Sandhya
- Wang, Jue
- Boyer, Michelle
- Humphrey, Kathryn
- Freise, Kevin J
- Salem, Ahmed Hamed
- Seymour, John F
- Kater, Arnon P
- Miles, Dale
Producer: 20200910
In:
Clinical pharmacokinetics vol. 58
Availability: No items available.
|
|
|
10331.
|
|
|
|
10332.
|
|
|
|
10333.
|
|
|
|
10334.
|
|
|
|
10335.
|
|
|
|
10336.
|
|
|
|
10337.
|
|
|
|
10338.
|
|
|
|
10339.
|
|
|
|
10340.
|
Humanized anti-CD20 monoclonal antibody (Rituximab) in post transplant B-lymphoproliferative disorder: a retrospective analysis on 32 patients. [electronic resource] by
- Milpied, N
- Vasseur, B
- Parquet, N
- Garnier, J L
- Antoine, C
- Quartier, P
- Carret, A S
- Bouscary, D
- Faye, A
- Bourbigot, B
- Reguerre, Y
- Stoppa, A M
- Bourquard, P
- Hurault de Ligny, B
- Dubief, F
- Mathieu-Boue, A
- Leblond, V
Producer: 20000330
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 11 Suppl 1
Availability: No items available.
|